CLOFIBRATE-INDUCED NEOPLASTIC DEVELOPMENT IN THE RAT-LIVER IS ASSOCIATED WITH DECREASED CONNEXIN-32 EXPRESSION BUT NOT WITH A COORDINATED SHIFT IN EXPRESSION OF MARKER ENZYMES
H. Tsuda et al., CLOFIBRATE-INDUCED NEOPLASTIC DEVELOPMENT IN THE RAT-LIVER IS ASSOCIATED WITH DECREASED CONNEXIN-32 EXPRESSION BUT NOT WITH A COORDINATED SHIFT IN EXPRESSION OF MARKER ENZYMES, Toxicology letters, 82-3, 1995, pp. 693-699
Altered enzyme phenotype and expression of connexin 32 (Cx32), a gap j
unction protein were studied during the development of rat liver tumor
s induced by the non-genotoxic carcinogen, clofibrate. (1) In contrast
to previous findings for nitrosamine-induced lesions. preneoplastic e
nzyme-altered foci (EAF) and neoplastic nodules (NN) lacked any clear
association with degree of altered enzyme expression because of an alm
ost complete negativity for GST-P and GGT. (2) Immunohistochemically d
emonstrated Cx32 spots on the hepatocyte membranes showed a clear decr
ease in clofibrate-induced lesions. (3) Naturally occurring EAF demons
trating GST-P and/or GGT positivity did not show a significant decreas
e of Cx32 counts suggesting a reversible nature. Therefore, the Cx32 d
ecrease appears closely linked to progression of hepatocarcinogenesis
irrespective of the enzyme phenotype of neoplastic focal lesions and t
he carcinogens used for their induction.